TRUMENBA: payments to doctors
Payments that named TRUMENBA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $2.1M
- Providers
- 30,496
- Transactions
- 71,241
- Average per transaction
- $29
The per-transaction average — $29 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 30,496 providers the average total is $68, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Pfizer | $2,045,430 | 98.9% |
| Pfizer Pharmaceuticals LLC | $17,495 | 0.8% |
| PBG Puerto RICO LLC | $4,896 | 0.2% |